Expression of miR-191 and miR-221 in hepatocellular carcinoma and its clinical significance

Chinese Journal of Pathology

Volumn 42, Issue 6, 2013, Pages 397-398

  Dang, Yi Wu ^a   Chen, Gang ^a   Liao, Yan ^a   Wang, Li ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN191 MICRORNA, HUMAN; MIRN221 MICRORNA, HUMAN; PARAFFIN;

ARTICLE; CANCER STAGING; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PARAFFIN EMBEDDING; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84880407584     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2013.06.009     Document Type: Article

References (9)

1. Braconi C., Henry JC., Kogure T, et al. The role of microRNAs in human liver cancers. Semin Oncol, 2011, 38(6):752-763.
2. Ura S, Honda M, Yamashita T, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology, 2009, 49(4):1098-1112.
3. He Y, Cui Y, Wang W, et al. Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma. Neoplasia, 2011, 13(9):841-853.
4. Elyakim E, Sitbon E, Faerman A, et al. HsamiR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res, 2010, 70(20):8077-8087.
5. Cramantieri L, Fomari F, Ferracin M, et al. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res, 2009, 15(16):5073-5081.
6. Fu X, Wang Q, Chen J, et al. Clinical significance of miR-221 and its inverse correlation with p27(Kipl) in hepatocellular carcinoma. Mol Biol Rep, 2011, 38 (5):3029-3035.
7. Chen G, Kronenberger P, Teugels E, et al. Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells. Biol Proced Online, 2010, 13:1.
8. Chen G, Kronenberger P, Umelo IA, et al. Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction. Anal Biochem, 2010, 398(2):266-268.
9. Arzt L, Kothmaier H, Quehenberger F, et al. Evaluation of formalin-free tissue fixation for RNA and microRNA studies. Exp Mol Pathol, 2011, 91(2):490495.